Patrik Eriksson

Patrik Eriksson

SVP and President of Nobel Biocare, until December 31, 2023atEnvista Holdings· In proxies 2021–2023

Pay in FY2022-17% from the year before

Patrik Eriksson was paid $1.7M in FY2022 (Dec), down 17%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Envista Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Envista HoldingsPublic company · 5 yr
    • SVP and President of Nobel Biocare, until December 31, 20232021 – Present · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?